Serac Healthcare

Dr Tatjana Gibbons, an investigator on the study from the Nuffield Dept of Women's & Reproductive Health, University of Oxford gave a Top Rated Oral Presentation on our DETECT endometriosis imaging study at the European Association of Nuclear Medicine (EANM) annual congress earlier this week.   The presentation at EANM added to the initial findings as previously presented at two women’s health congresses earlier in the year, indicating that 99mTc-maraciclatide has potential as a non-invasive test for early-stage endometriosis. The presentation at EANM gave the Oxford University team the opportunity to discuss the potential of our molecular imaging agent with this important nuclear medicine audience. #endometriosis #womenshealth #molecularimaging #diagnosticimaging #medicalimaging #precisionmedicine #nuclearmedicine #EANM24 Hermes Medical Solutions Spectrum Dynamics Medical

Exciting news from the European Association of Nuclear Medicine (EANM) meeting in Hamburg this evening: our presentation on the DETECT study assessing maraciclatide as an imaging agent for endometriosis was included in the opening Highlights Lecture at the congress as “one to watch” . Dr Tatjana Gibbons, one of the key investigators on the study from the Nuffield Dept of Women's & Reproductive Health, University of Oxford, will be presenting findings from the study in a Top Rated Oral Presentation session: Session Date: Sunday, October 20, 2024 Session Time: 9:45AM - 11:15AM Presentation Number: OP-116 Session Number: 307 Session Title: TROP Session: Paediatrics Committee: Paediatric Nephrourology & Others Session Hall: Hall Y10-Y12 Alongside Tatjana and other members of the Serac Healthcare, Dr Munir Ghesani MD, FACNM, FACR, FSNMMI, Chief Medical Officer, United Theranostics and Past President, Society of Nuclear Medicine and Medical Imaging (SNMMI) will also be available to discuss the molecular imaging techniques used in the study. We hope to see you there! #endometriosis #womenshealth #molecularimaging #diagnosticimaging #medicalimaging #precisionmedicine #nuclearmedicine #EANM24 Hermes Medical Solutions Spectrum Dynamics Medical

Further research on the development of AI tools to enhance the potential of ⁹⁹ᵐTc-maraciclatide as a new imaging marker has been presented today by Robert Cobb from the School of Biomedical Engineering & Imaging Sciences, King’s College London (KCL). A poster at the annual conference of the Medical Image Computing and Computer Assisted Intervention Society (MICCAI Society) illustrates the latest methodology used in the ongoing research collaboration led by Professor Andrew Reader and Professor Gary Cook at KCL to develop AI tools to help clinicians read and interpret scans using ⁹⁹ᵐTc-maraciclatide. For more details, please see the press release here: https://lnkd.in/eQMJyu4s And high res poster here: https://lnkd.in/evi8UQux ⁹⁹ᵐTc-maraciclatide is for investigational use only and is not approved by the FDA or UK and European regulatory authorities. #molecularimaging #medicalimaging #AI #machinelearning #rheumatoidarthritis #endometriosis #nuclearmedicine #precisionmedicine #MICCAI2024 #inflammatoryarthritis

We are preparing for the annual European Association of Nuclear Medicine (EANM) congress taking place in Hamburg from 19-23 October.  David Hail Paul Cload and Jon Barnett will be attending and available to discuss the ongoing DETECT study which is evaluating maraciclatide as a molecular imaging marker for endometriosis.   Dr Tatjana Gibbons, one of the key investigators on the study from the Nuffield Dept of Women's & Reproductive Health, University of Oxford, will be presenting findings from the study in a Top Rated Oral Presentation session: Session Date:                          Sunday, October 20, 2024 Session Time:                          9:45:00 AM - 11:15:00 AM Presentation Number:          OP-116 Session Number:                     307 Session Title:                            TROP Session: Paediatrics Committee: Paediatric Nephrourology & Others Session Hall:                             Hall Y10-Y12   The abstract “Visualisation of Superficial Peritoneal Endometriosis with 99mTc-maraciclatide” has now been published in the EANM ’24 Abstract book here (until 7 November): https://lnkd.in/ez-7hM-8 and our website here: https://lnkd.in/ezkX2rm7   #endometriosis #womenshealth #molecularimaging #diagnosticimaging #medicalimaging #precisionmedicine #nuclearmedicine #EANM2024 Hermes Medical Solutions Spectrum Dynamics Medical

Our Chief Executive is attending this event in London tomorrow. Please do get in touch if you'd like to meet with him there.

We are delighted to announce that we have been selected as a spoke in the Advanced Research Projects Agency for Health (ARPA-H) Investor Catalyst Hub network. This US based consortium has been created to fast-track the development of medical innovations for those in critical need. It brings together government, industry, finance, healthcare, and academia and will enable us to access initiatives within the network in pursuit of better health outcomes for all. #ARPAH #ARPANETH #InvestorCatalystHub #HealthInnovation #womenshealth #precisionmedicine #endometriosis #rheumatoidarthritis

Further research from our ongoing collaboration with the School of Biomedical Engineering & Imaging Sciences, King’s College London - which is investigating potential AI tools to help clinicians read and interpret scans using ⁹⁹ᵐTc-maraciclatide - will be presented at the annual conference of the Medical Image Computing and Computer Assisted Intervention Society (MICCAI Society) taking place next week from 6-10 October in Marrakesh, Morocco.   A poster authored by Robert Cobb, Professor Gary Cook and Professor Andrew Reader will be available throughout the conference onsite and on the virtual platform together with the accepted paper, and will be presented by Robert: On Wednesday, October 9, 2024, 10:30 to 11:30 At Poster Session 5: Image Registration, Computer Aided Diagnosis 2, and Transparency, Fairness and Uncertainty 2 Titled: W-AM-133: Improved Classification Learning from Highly Imbalanced Multi-Label Datasets of Inflamed Joints in [⁹⁹ᵐTc]Maraciclatide Imaging of Arthritic Patients by Natural Image and Diffusion Model Augmentation   Maraciclatide is in development to diagnose and detect inflammation in patients with inflammatory arthritis and endometriosis. The development of AI tools could enhance the potential of maraciclatide as a new imaging marker. Maraciclatide is for investigational use only and is not approved by the FDA or UK and European regulatory authorities. #molecularimaging #medicalimaging #AI #machinelearning #rheumatoidarthritis #endometriosis #nuclearmedicine #precisionmedicine #MICCAI2024 #inflammatoryarthritis   

Earlier this year members of the Serac Healthcare team enjoyed participating at the inaugural FemTech Forward Conference, organised by the Oxford FemTech Society to showcase the latest advances in women’s health, and engaging with delegates keen to learn more about the DETECT study investigating maraciclatide as a novel molecular imaging agent for superficial peritoneal endometriosis. A write up of the event has recently been published (see below). Many thanks to Christiane Hagel for inviting us along.

Congratulations to Professor Krina Zondervan, head of the Nuffield Dept of Women's & Reproductive Health, University of Oxford and Co-Director at EndoCaRe Oxford 🎗️ and Professor Andrew Horne, Director of the Centre for Reproductive Health, University of Edinburgh who have been admitted as new Fellows to the The Academy Of Medical Sciences in recognition of their outstanding work in the field of endometriosis research. We are fortunate to benefit directly from the exceptional expertise of Professor Zondervan as one of the principal investigators on our DETECT trial investigating maraciclatide as a molecular imaging diagnostic tool for endometriosis.

Our Chief Executive, David Hail, will be attending this significant women’s healthcare meeting in Boston next week. Please do get in touch if you’d like to meet with him there.